CCR5-Δ32
gene variant
≈ 4 min read
Names in other languages
- SvenskaCCR5-delta 32
- EnglishCCR5-Δ32
- 한국어CCR5-Δ32
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CCR5-Δ32 (or CCR5-D32 or CCR5 delta 32) is a genetic variant of the CCR5 gene characterized by a 32-base-pair deletion that produces a nonfunctional receptor on the surface of immune cells, conferring strong resistance to HIV-1 infection in individuals who inherit two copies of the mutation (homozygotes). CCR5 Δ32 is a 32-base-pair deletion that introduces a premature stop codon into the CCR5 receptor locus, resulting in a nonfunctional receptor.
CCR5 is required for M-tropic HIV-1 virus entry. Individuals homozygous (denoted Δ32/Δ32) for CCR5 Δ32 do not express functional CCR5 receptors on their cell surfaces and are resistant to HIV-1 infection, despite multiple high-risk exposures.
Individuals heterozygous (+/Δ32) for the mutant allele have a greater than 50% reduction in functional CCR5 receptors on their cell surfaces due to dimerization between mutant and wild-type receptors that interferes with transport of CCR5 to the cell surface. Heterozygote carriers are resistant to HIV-1 infection relative to wild types and when infected, heterozygotes exhibit reduced viral loads and a 2-3-year-slower progression to AIDS relative to wild types.
Heterozygosity for this mutant allele also has shown to improve one's virological response to anti-retroviral treatment. CCR5 Δ32 has a heterozygote frequency of 9% in Europe, and a homozygote frequency of 1%.…
CCR5-Δ32 (or CCR5-D32 or CCR5 delta 32) is a genetic variant of the CCR5 gene characterized by a 32-base-pair deletion that produces a nonfunctional receptor on the surface of immune cells, conferring strong resistance to HIV-1 infection in individuals who inherit two copies of the mutation (homozygotes). CCR5 Δ32 is a 32-base-pair deletion that introduces a premature stop codon into the CCR5 receptor locus, resulting in a nonfunctional receptor.
CCR5 is required for M-tropic HIV-1 virus entry. Individuals homozygous (denoted Δ32/Δ32) for CCR5 Δ32 do not express functional CCR5 receptors on their cell surfaces and are resistant to HIV-1 infection, despite multiple high-risk exposures.
Individuals heterozygous (+/Δ32) for the mutant allele have a greater than 50% reduction in functional CCR5 receptors on their cell surfaces due to dimerization between mutant and wild-type receptors that interferes with transport of CCR5 to the cell surface. Heterozygote carriers are resistant to HIV-1 infection relative to wild types and when infected, heterozygotes exhibit reduced viral loads and a 2-3-year-slower progression to AIDS relative to wild types.
Heterozygosity for this mutant allele also has shown to improve one's virological response to anti-retroviral treatment. CCR5 Δ32 has a heterozygote frequency of 9% in Europe, and a homozygote frequency of 1%. Recent research indicates that CCR5 Δ32 enhances cognition and memory.
In 2016, researchers showed that removing the CCR5 gene from mice significantly improved their memory. CCR5 is a powerful suppressor for neuronal plasticity, learning, and memory; CCR5 over-activation by viral proteins may contribute to HIV-associated cognitive deficits.
Genetic studies published in 20251 revealed that the CCR5Δ32 deletion is part of a specific haplotype, termed Haplotype A, which includes 86 linked variants in high linkage disequilibrium (LD). Within this haplotype, two single nucleotide polymorphisms (SNPs), rs113341849 and rs113010081, are in perfect LD (r² = 1) with CCR5Δ32 and thus statistically indistinguishable in genotype data.
This haplotype is located on chromosome 3 (3p21.31), spans approximately 0.19 megabases, and encompasses several chemokine receptor genes, including CCR3, CCR2, CCR5, and CCRL2. Although two additional haplotypes, B and C, were identified in the region, only Haplotype A carries the CCR5Δ32 deletion.
The configuration of the three haplotypes—A, B, and C—was illustrated in Figure 1A of the study.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377962791 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “CCR5-Δ32” publication date (×1) · confidence 0.95 revision URL